NCT07051369Active, not recruiting
Frequency of Portal Hypertension Among Patient With Cirrhotic Liver With Ultrasound
Source: ClinicalTrials.gov · Last updated 4 Jul 2025
Brief summary (registry, in English)
Portal hypertension is a common and serious complication of liver cirrhosis, often leading to life-threatening conditions such as variceal bleeding, ascites, and hepatic encephalopathy.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 150 (actual)
- First submitted
- 26 Jun 2025
- Start date
- 17 Mar 2025
- Primary completion date
- 1 Sept 2025
- Lead sponsor
- Superior University
- Diseases
- High blood pressure
- NCT number
- NCT07051369
What you commit to
- Study type: Observational
- Participants enrolled: 150
- From 17 Mar 2025 to the primary completion date, 1 Sept 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Non-cirrhotic liver patients
- Non-cooperative patients.Patients who do not provide written informed consent
Who the study is looking for
- Patients with a history of chronic liver disease (CLD) will be included.
- Both male and female patients will be included.
Age in the registry: 20 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sheikh Zayed college/hospital Coordinator of this site? Confirm its status | Rahim Yar Khan | Pakistan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.